| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,795 |
13,599 |
$928K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,947 |
15,774 |
$579K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,947 |
10,985 |
$420K |
| 80053 |
Comprehensive metabolic panel |
21,774 |
17,441 |
$178K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,432 |
17,873 |
$148K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,582 |
1,134 |
$59K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,280 |
4,190 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,764 |
2,452 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
726 |
682 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,810 |
2,457 |
$35K |
| 81003 |
|
16,863 |
13,457 |
$35K |
| 70450 |
Computed tomography, head or brain; without contrast material |
521 |
430 |
$32K |
| 87070 |
|
2,902 |
2,547 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
1,813 |
1,555 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
372 |
345 |
$15K |
| 84703 |
|
2,690 |
2,174 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
3,387 |
2,807 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
365 |
305 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,252 |
981 |
$10K |
| 84484 |
|
1,796 |
1,403 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
170 |
126 |
$9K |
| 83690 |
|
1,391 |
1,165 |
$7K |
| 80306 |
|
645 |
496 |
$6K |
| 30140 |
|
57 |
38 |
$6K |
| 85610 |
|
2,087 |
1,712 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
356 |
329 |
$5K |
| 80061 |
Lipid panel |
390 |
347 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
475 |
374 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
34 |
32 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
275 |
239 |
$4K |
| G0378 |
Hospital observation service, per hour |
116 |
76 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
67 |
37 |
$3K |
| 83880 |
|
196 |
167 |
$3K |
| 85730 |
|
2,085 |
1,710 |
$3K |
| 87420 |
|
186 |
163 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
18 |
13 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
254 |
210 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
23 |
13 |
$2K |
| 82947 |
|
696 |
515 |
$2K |
| 85027 |
|
415 |
355 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
211 |
156 |
$1K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
17 |
13 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,699 |
1,309 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
48 |
38 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$897.92 |
| 82607 |
|
52 |
49 |
$734.76 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
53 |
26 |
$673.53 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
12 |
$672.63 |
| 84439 |
|
98 |
90 |
$635.67 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,167 |
1,820 |
$622.22 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,457 |
2,014 |
$603.33 |
| 86803 |
|
72 |
48 |
$545.61 |
| 82746 |
|
40 |
37 |
$433.80 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
32 |
13 |
$432.12 |
| 74022 |
|
26 |
25 |
$405.92 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
24 |
$404.96 |
| 83735 |
|
98 |
79 |
$378.91 |
| 87581 |
|
18 |
13 |
$332.40 |
| 87486 |
|
18 |
13 |
$332.40 |
| 87653 |
|
24 |
14 |
$296.52 |
| 87210 |
|
68 |
53 |
$260.15 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
895 |
764 |
$252.26 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
42 |
38 |
$251.44 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,231 |
2,719 |
$180.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
547 |
384 |
$174.15 |
| 93017 |
|
15 |
12 |
$168.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
270 |
219 |
$153.64 |
| 82553 |
|
35 |
27 |
$153.09 |
| 83605 |
|
19 |
14 |
$148.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
677 |
560 |
$136.00 |
| 87040 |
|
17 |
12 |
$111.21 |
| 82550 |
|
37 |
29 |
$105.60 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
32 |
26 |
$103.53 |
| 86592 |
|
31 |
26 |
$103.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,279 |
1,037 |
$70.49 |
| 87015 |
|
24 |
14 |
$60.60 |
| 86140 |
|
28 |
24 |
$58.87 |
| 82043 |
|
17 |
14 |
$40.40 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
183 |
125 |
$29.15 |
| 36415 |
Collection of venous blood by venipuncture |
4,076 |
2,809 |
$18.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
184 |
161 |
$15.88 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
51 |
46 |
$14.64 |
| J2704 |
Injection, propofol, 10 mg |
696 |
485 |
$3.50 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
26 |
24 |
$2.86 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
33 |
25 |
$2.49 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
15 |
14 |
$0.02 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,395 |
1,256 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
13 |
$0.00 |
| Q9960 |
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
187 |
165 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
17 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
605 |
365 |
$0.00 |
| 94760 |
|
157 |
129 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
36 |
25 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
31 |
27 |
$0.00 |